Presentation at Bloom Burton & Co. Healthcare Investor Conference

DRI Healthcare Announces Closing of Internalization Transaction

DRI Healthcare Trust Comments on FDA Delay for KalVista Pharmaceuticals' Sebetralstat PDUFA Goal Date Due to FDA Reso...

DRI Healthcare Trust Announces Appointment of Annalisa King to Board of Trustees and as Chair of the Audit Committee